Which drug is a xanthine oxidase inhibitor used for chronic gout management?

Study for the NBME Form 13 Test with our comprehensive quiz collection, featuring flashcards and multiple-choice questions to ensure your readiness. Enhance your knowledge with detailed explanations for each question.

Multiple Choice

Which drug is a xanthine oxidase inhibitor used for chronic gout management?

Explanation:
The key idea is lowering uric acid production to prevent chronic gout flares. A xanthine oxidase inhibitor accomplishes this by blocking the enzyme that converts hypoxanthine to xanthine and xanthine to uric acid, thereby reducing serum urate levels. Allopurinol is the classic agent in this class and is used for long-term urate lowering and tophi management in chronic gout. Colchicine works by inhibiting neutrophil activity to reduce inflammation during flares, not by lowering uric acid. Indomethacin is an NSAID that provides symptomatic relief for acute gout. Pegloticase breaks down uric acid to allantoin via uricase, which is used in refractory cases and is not a xanthine oxidase inhibitor.

The key idea is lowering uric acid production to prevent chronic gout flares. A xanthine oxidase inhibitor accomplishes this by blocking the enzyme that converts hypoxanthine to xanthine and xanthine to uric acid, thereby reducing serum urate levels. Allopurinol is the classic agent in this class and is used for long-term urate lowering and tophi management in chronic gout.

Colchicine works by inhibiting neutrophil activity to reduce inflammation during flares, not by lowering uric acid. Indomethacin is an NSAID that provides symptomatic relief for acute gout. Pegloticase breaks down uric acid to allantoin via uricase, which is used in refractory cases and is not a xanthine oxidase inhibitor.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy